media planner - images2.advanstar.comimages2.advanstar.com/ayl/act_2016completemediakit... ·...
TRANSCRIPT
MEDIA PLANNERA GLOBAL BRAND FOR A GLOBAL MARKET
2016WWW.APPLIEDCLINICALTRIALSONLINE.COM
YOUR PEER-REVIEWED GUIDE TO GLOBAL CLINICAL TRIALS MANAGEMENT
Applied Clinical Trials is the authoritative, peer-reviewed resource and thought leader for the global community that designs, initiates, manages, conducts and monitors clinical trials. We provide this information that the clinical trials community wants in the multiplatform format that they want it in; print, online, webinars, white papers, video native content and newsletters.
Focused ContentOur authors—who share their knowledge and offer practical experiences with our readers—are executives, managers, and investigators who are involved in every stage of clinical trials from study design and protocol development, to data management, subject recruitment, budget negotiations, and site monitoring.
Esteemed Editorial Advisory BoardOur Editorial Advisory Board ensures the credibility and accuracy of our content through their expertise. The Board members come from all walks of the industry—CROs, IRBs, regulatory agencies, technology and pharmaceutical companies—and have experience with clinical trials management, design, GCP, recruitment, data management, and informed consent and monitoring, among other � elds. These international experts offer their mastery to review manuscripts, suggest topics, and advise editors on industry issues. Through their contributions, our readers bene� t by receiving credible, practical, and relevant articles and commentaries.
Project Managers CommitteeLaunched last year, the Project Managers Committee serves as the voice for Applied Clinical Trials’ loyal audience segment, project managers, which account for 25% of our audience The PMC works closely with the editors to guide the content that is important to them and provides comments and takeaways specifc to this audience.
Original Reports
View from BrusselsA discussion and coverage of latest events, and EU regulations that affect the clinical trials industry in Europe.
View from WashingtonOur seasoned Washington, DC reporter attends industry and FDA events to keep readers on top of the regulatory landscape in the United States.
Clinical Trial InsightsKenneth Getz, a well-known industry expert, provides insightful data, opinion and information culled from his � rst-hand research from Tufts CSDD, CenterWatch and CISCRP.
A Closing ThoughtInsightful opinions and information from thought leaders in the clinical trials community.
Editorial Mission
Our Audience
**July 2015
Readership Study Conducted by
Advanstar Research Services
mon
keyb
usin
essim
ages
/Get
ty Im
ages
Functions** Percentage
Research & development 18.41%
Project management 15.42%
Clinical research coordinator (CRC/study coordinator/research nurse)
10.95%
Regulatory affairs/compliance/drug safety/pharmacovigilance marketing
8.46%
Clinical research associate (CRA/monitor)
6.97%
Corporate management (Medical director/affairs)
5.97%
Academic research 5.97%
GCP auditing/QA/QC 5.47%
Data management/analysis/biostatistics
2.99%
IT management 1.99%
Government 1.99%
Clinical supplies/materials/contracting
1.00%
Laboratory analysis 0.50%
Investigator 0.50%
Responses Other (please specify)
13.43%
We’re Well ConnectedApplied Clinical Trials connects you to the global audience that is most receptive to your marketing message.
58.17% Visited a company’s website
8.17% Contacted an advertiser byphone or e-mail
3.85% Purchased/ordered a product/service
10.58% Recommended product or service
17.31% Filed advertisement for future reference
Our audience takes action as a result of seeing advertisements in Applied Clinical Trials*
Applied Clinical Trials has an active audience who buys, recommends, or approves the purchase of an array of products and services for their organization. When you advertise in Applied Clinical Trials, you can be assured that your campaign will be seen by the industry’s top decision makers.
53.27% CROs
38.69% Education/trainers
36.68% EDC
42.21% Regulatory services
37.69% Clinical supplies
27.64% Subject recruitment
44.22% Laboratories
37.19% Information technology
26.13% Partnerships
19.60% Packaging/labels
21.61% Marketing
2.51% Responses Other (please specify)
*July 2015 Readership Study Conducted by Advanstar Research Services
Our audience utilizes the industry’s top products and services*
Purchasing Power
2016 Editorial CalendarISSUE FOCUS SUPPLEMENT/eBOOK BONUS DISTRIBUTION Value Added
February/MarchAd Close: January 13Material deadline: January 20
Patient Engagement
Risk-Based Monitoring (February)Clinical Trial Management (March)
DIA Annual EuroMeeting, 6-8 April 2016, Hamburg, Germany
April/MayAd Close: March 16Material deadline: March 21
Precision Medicine
Cardiac Safety (April)Oncology Trials (May)
ACRP Global Conference &Exhibition,April 25-28, Atlanta, Georgia
ASCO Annual Meeting, June 3-7, Chicago, IL
BIO International Convention, June 6-9, San Francisco, CA
June/JulyAd Close: May 13Material deadline: May 18
eSource/DataIntegration
Regulatory Issuesin Clinical Trials (July)
DIA Annual Meeting, June 26-30, Philadelphia, PA
Readex Ad Performance Study
August/SeptemberAd Close: July 18Material deadline: July 21
Clinical TrialsInnovation
Technology ThatTouches thePatient (September)
IIR Partnerships in Clinical TrialsOctober 5-7, Boston, MA
October/NovemberAd Close: September 15Material deadline: September 20
Clinical SupplyTrends
Risk-BasedMonitoring (November)
December/January 2017Ad Close: November 10Material deadline: November 15
Big Data,Meaningful Data
The HealthcareConvergence withClinical Trials (January 2017)
AppliedClinicalTrialsOn-line.com is a comprehen-sive website that provides clinical trial professionals with relevant information that can be immediately applied to their work. View-ers frequently visit the site to access technology up-dates, current product re-leases, latest FDA news, articles and other critical information applicable for managing clinical trials.
Online Advertising Optionsappliedclinicaltrialsonline.com
additional advertising options• Expandable Ad • Video Ad • Rich Media
• Sponsored Content Block • Ad Retargeting
Sponsored Link10 words of text + URL
Banner 468 × 60
up to 5 rotations
Skyscraper 160 × 600
up to 5 rotations
Leaderboard728 × 90
up to 5 rotations
Page Peel
Big box 300x250 up to 5 rotations
Interstitial Ad640 × 480
Polite footer970x90 expandable to
970x250
White Paper Library
Drive Quali� ed Leads from ACT’s White Paper e-Library
Applied Clinical Trials’ white paper e-Library is a feature of ACT’s website, hosting white papers by the industry’s leading solution providers.
The program includes posting of your paper in our white paper library, and promotion of your asset in 2 e-Learning newsletters during the month of your posting.
In order to download your white paper, the viewer must complete a short response form including contact information and demographics. After the white paper is sent, you will receive on-demand or weekly reports on all of your leads.
MarketplaceLogo + 25 words
Big Box300 × 2502 available
Banner or Text Ad468 x 60 or 65 words2
available
Text Ad65 words
Text Ad65 words
2 available
Leaderboard728 × 90
1 available
Big Box300 × 2502 available
Banner or Text Ad468 x 60 or 65 words
2 available
ACT Direct is published every Tuesday to highly engaged clinical trials professionals. Each edition features a premium collection of news, blogs, an advertiser Marketplace, events/webcasts, and more.
Each ACT Direct features topic-speci� c news, articles and events on a rotating basis. Those topics include: Risk-Based Monitoring (RBM), Oncology, Regulatory and Mobile Health.
Online Advertising Optionse-Newsletters
ACT Trends is a delivered every 2nd and 4th Wednesday to provide the most popular clinical trials news and articles and highlights what’s trending on social media.
JANUARY 5 (Oncology)12 (RBM)13 ACT trends19 (Regulatory)26 (Mobile Health)27 ACT trends
FEBRUARY 2 (Oncology) 9 (RBM)10 ACT trends16 (Regulatory)23 (Mobile Health)27 ACT trends
MARCH 1 (Oncology) 8 (RBM) 9 ACT trends15 (Regulatory) 22 (Mobile Health)23 ACT trends29 (Oncology)
APRIL 5 (RBM)12 (Regulatory)13 ACT trends19 (Mobile Health)26 (Oncology)27 ACT trends
MAY 3 (RBM)10 (Regulatory)11 ACT trends17 (Mobile Health)24 (Oncology)25 ACT trends31 (RBM)
JUNE 7 (Regulatory) 8 ACT trends14 (Mobile Health)21 (Oncology)22 ACT trends28 (RBM)
JULY 5 (Regulatory)12 (Mobile Health)13 ACT trends19 (Oncology)26 (RBM)27 ACT trends
AUGUST 2 (Regulatory) 9 (Mobile Health)10 ACT trends16 (Oncology)23 (RBM)24 ACT trends30 (Regulatory)
SEPTEMBER 6 (Mobile Health)13 (Oncology)14 ACT trends20 (RBM)27 (Regulatory)28 ACT trends
OCTOBER 4 (RBM)11 (Mobile Health)12 ACT trends18 (Oncology)25 (RBM)26 ACT trends
NOVEMBER 1 (Regulatory) 8 (Mobile Health) 9 ACT trends15 (Oncology)22 (RBM)23 ACT trends29 (Regulatory)
DECEMBER 6 (Mobile Health)13 (Oncology)14 ACT trends20 (RBM)
ENDS
2016 e-Newsletter Schedule
ACT Direct 2016(Every Tuesday, with
rotating subtopic)
ACT Trends 2016(2nd and 4th Wednesday)
additional advertising options• Live Audio with Slides • Custom Survey• Whitepaper/Executive summary • Infographics
Online Advertising Options Digital Edition
Webcast
Applied Clinical Trials’ Digital Edition features the same authoritative content and the same look and feel as our print edition. What differentiates the Dig-ital Edition is it allows anyone involved in clinical trials around the globe to access our peer-reviewed articles, regular expert columnists, and staff writ-ten news and updates in real-time on the web. The Applied Clinical Trials Digital Edition is delivered free via e-mail to subscribers, or global profession-als can access it for free on our website.
Ask your representative for further detail and cost
We offer a variety of webcast formats and suggested topics to provide our audiences with insights on current news, new products and applications, and important trends. ACT offers you the opportunity to participate in our webcasts as an exclusive sponsor. Our editorial staff works with you to customize the panel discussion/presentation to attract the most relevant listener base and to demonstrate your connec-tion and/or expertise on the topic(s).
Beyond the bene� ts of associating yourself with thought leadership and high quality content, our web-casts feature a powerful lead generation tool allowing you to retrieve quali� ed leads from a real time report-ing platform that includes contact info, demographics and other qualifying questions from your webcast at-tendees and all registrants. An aggressive, targeted and integrated marketing campaign is used to lever-age the extensive reach of our brands to enhance your brand equity and generate a quali� ed audience for your sales and marketing efforts.
Extend Reach and Duration: Drive Customer EngagementAn Applied Clinical Trials webcast can be enhanced by creating a whitepaper/executive summary or infographic transforming the event into a far-reaching thought leadership campaign. This integrated content program drives attendance to the webcast, live and on-demand and extends reach, duration and access to the content. Aggressive marketing of the webcast and accompanying content provides twelve (12) full months of continuous branding and lead generation.
Online Advertising Options
What it does• Publishes webcast content cross-platform• Extends reach, duration & brand visibility• Increases access & engagement
What you get• White Paper/ Executive Summary We transcribe the webcast and write a White Paper/Executive
Summary of the program, recognizing your company’s participation and support• Hosted on the brand website for 12 months of seamless downloading• Integrated into the webcast promotion as an attendee take-away, driving attendance to the event-
live and on-demand • Aggressively Promoted to the brand community via dedicated eBlasts, social media, eNewsletters,
print ads and/or online• Lead Gen Capturing contact & demographic information required at registration
Enhanced Webcast Content Programs
Custom Content Programs
White Paper
Webcast
Infographic
Applied Clinical Trials offers a variety of pod-casts to provide our audiences with keen in-sights on current news, new products, applica-tions and important trends. Our editorial staff works with you to customize programming to attract the most relevant listener base and to demonstrate your connection or expertise with the topic(s). Our sponsored podcast program delivers a unique combination of an easily used media format in high demand, fl exible lead gen-eration and multiple points of access from our electronic products to your digital assets.
The Channel for GlobalClinical Trials Management
Connect with customers and prospects like never before with this successful, new interactive digital platform.
• ACT TV offers a centralized location for your resources on new product releases, services and solutions
• Increase awareness by driving a targeted audience to one location to learn about your company
• Utilize this tool to share your products and programs with decision-makers who want to learn about effective and ef� cient solutions to challenges within the tightly regulated pharmaceutical environment and makes ACT a must-read.
Ask your representative for further detail and cost
Audio Podcast
ACT TV
Online Advertising Options
NEW DIGITAL OPPORTUNITY
additional advertising options• Single sponsorship & multiple sponsorship available
Online Advertising Options
2016 E-BOOK SCHEDULE MONTH E-BOOK
February/March Risk-Based Monitoring/Clinical Trial Management
April/May Cardiac Safety/Oncology Trials
June/July Regulatory Issues in Clinical Trials
August/September Technology That Touches the Patient
October/November Risk-Based Monitoring
December/January 2016 The Healthcare Convergence with Clinical Trials
Deliver the information that matters the most. e-Book Sponsorship Program is a digital avenue that delivers relevant content to a targeted, responsive clinical trials audience.Responsive readers take action! Reach the core group!Each focused e-book will be delivered to a highly targeted audience of clinical trials professionals involved in every phase of clinical trials. Your sponsorships will be supported with a continuous marketing campaign of banner ads on web site and e-newsletters, e-mail blasts and print/digital publications.
e-Book
What it does
• Podcast Interview by a contributing editor repurposed in a Print Summary.
What you get
• Podcast Interview Record Q&A interview of executive by Advanstar contributing editor
• Published into a two-page summary
• Hosted on the brand website on-demand for 12 months: podcast & summary
• Printed in the brand magazine as sponsored content (optional)
• Aggressively Promoted to the brand community via dedicated eBlasts, social media, eNewslet-ters and online
• Lead Gen Capturing contact & demographic information re-quired at registration (optional)
Dedicated Dialogue
See our September 2015 eBook on RBM here
What it does
• Delivers the right content to the right person at the right time in the right place
• Positions you as a thought-leader within your industry • Ampli� es the conversation
What you get
• Creation of content: Special Report, Feature Article, Dedicated Dialogue
• Published in the print magazine as sponsored content (optional)• Aggressively Promoted to the brand community via dedicated
eBlasts, social media, eNewsletters and hosted online• Ownership of content for your own marketing efforts, including
reprints
Custom Publishing
What it does• Goal: Targeted distribution of your
message• Solution: Create and promote an
infographic that drives downloads of your message
What you get• Creation of Infographic based on
customer’s content & messaging• Hosting on the ACT website for 6
months• Promoted to the ACT community
for three months (6 deployments) • Ownership of the infograhic for use
in client’s marketing efforts
Content Ampli� cation
Lead Nurturing
Inbound marketing is a proven strategy that � lls your lead fun-nel and accelerates the conver-sion of leads to sales. Guided by our state-of-the art audience behavioral analysis, UBM Life Sciences’ content creation team can do the heavy lifting for you, drafting a strategic campaign and developing content that will get results. In addition to using this content in your UBM Life Sciences Inbound Campaign, you keep all rights to the ma-terial to use as you see � t.
What it does
• Expand Event Experience: Larger Audience, Greater Access• Prolong Value of Content: Extend Shelf Life & Duration• Maintain Audience: Connect Community & Drive Engagement 365
What you get• Production Services for streaming and/or cap-
ture of content• Hosted on the brand(s) website on-demand for
12 months • Aggressively Promoted to the brand community
via dedicated eBlasts, social media, eNewslet-ters and online
• Ownership of content for your own marketing efforts
Event Simulcast/On-Demand
Ad TargetingBrand Awareness + Brand RecallReach Targeted Decision MakersAd Retargeting is a powerful brand-building opportunity to showcase your message in front of Pharmaceutical Executive or Applied Clinical Trials’ community of pharma decision makers well beyond your visibility on the Pharmaceutical Executive or Applied Clinical Trials websites.
How Ad Retargeting WorksOnce a visitor leaves the Pharmaceutical Executive or Applied Clinical Trials website, they see your re-targeted display ad online, on any device, across the web. Your ad follows a targeted group of pharma decision makers long after they’ve left the Pharmaceu-tical Executive or Applied Clinical Trials website.
User is taken to your website
User visits PharmExec.com or AppliedClinicalTrialsOnline.com Your ad is prominently displayed
on PharmExec.com or AppliedClinicalTrialsOnline.com
User clicks on your ad
User visits other sites throughout the web
Your ad follows the user
additional advertising options• Sponsored Content Block • Ad Retargeting
Drive Traf� c… Awareness… Customer Engagement… Leads.
The Sponsored Content Block is an exclusive sole-sponsored resource section on PharmExec or Applied Clinical Trials’ website where your company can dis-seminate collateral, videos, whitepapers, research, drive website traf� c, generate leads, and more.
Sample Assets:
Sponsored Content Block
w
1x 3x 6x 12x 18x 24x 36xFull Page 7,115 7,010 6,885 6,700 6,550 6,390 6,295
2/3 Page 6,510 6,425 6,305 6,180 6,015 5,885 5,785
1/2 Page 5,625 5,515 5,460 5,300 5,215 5,115 5,035
1/3 Page 4,705 4,630 4,585 4,480 4,415 4,340 4,280
1/4 Page 4,185 4,115 4,080 3,995 3,945 3,905 3,840
Dimensions W H W H
Full Page 7 3/4˝ 10 1/2˝ Trim Size 7 3/4˝ 10 1/2˝
2/3 Page 4 1/2˝ 9 1/2˝ Bleed 8˝ 10 3/4˝
1/2 Page Island 4 1/2” 7˝ Live Matter 7 1/4˝ 10˝
1/2 Page Horz 6 3/4˝ 4 5/8˝ Spread Size 14 1/2˝ 9 1/2˝
1/2 Page Vert 3 3/8˝ 9 1/2˝ Bleed (Spread) 15 3/4˝ 10 3/4˝
1/3 Page Sq 4 1/2˝ 4 5/8˝
1/3 Page Vert 2 1/8˝ 9 1/2˝
1/4 Page 3 3/8˝ 4 5/8˝
Color Charges Special Positions
Metallic 1,205 Cover 2 745
Cover 3 745
Cover 4 1,245
Preferred Pos 620
Digital Ad Requirements1. Digital data is required for all ad submissions. Preferred format is PDF/X-1a. Note that a standard PDF is not a preferred format, files should be a
PDF/X-1a which is a PDF subset specific to printing. Publisher shall have no obligation or liability to Advertiser of any kind (including, without limitation, the obligation to offer Advertiser makegoods or any other form of compensation) if an ad is supplied to Publisher by Advertiser in any format other than our preferred formats. Non-preferred or non-acceptable formats will be charged a $150 processing fee. All files should be built to exact ad space dimensions purchased. For detailed instructions on preparing PDF/X-1a files and submitting ad files to the correct size, go to www.AdsAtAdvanstar.com or contact the production manager.
2. Publisher will not supply a faxed or soft proof for Advertiser-supplied files. Advertiser is solely responsible for preflighting and proofing all advertise-ments prior to submission to Publisher. If Publisher detects an error before going to press, Publisher will make a reasonable effort to contact Advertiser to give Advertiser an opportunity to correct and resubmit Advertiser’s file before publication.
3. Accepted Method of Delivery: The preferred method of delivering ad � les to Advanstar is via a web based ad uploader, www.AdsAtAdvanstar.com. Files can also be submitted on CD-R or DVD-R disc format.
4. Ad Proofs: To insure that Advertiser’s ad is reproduced correctly, a SWOP-certified color proof that has been made from the same file that Advertiser supplies to Publisher must be provided. Publisher cannot provide Advertiser any assurances regarding the accuracy of reproduction of any ad submit-ted without a SWOP proof. Publisher shall have no obligation or liability to Advertiser of any kind (including, without limitation, the obligation to offer Advertiser makegoods or any other form of compensation) for any ad supplied to Publisher by Advertiser without a SWOP proof.
2016 Print Advertising Rates US DOLLARS
Your Peer-reviewed Guide to Global CliniCal trials ManaGeMent appliedclinicaltrialsonline.com
1992–2014
ACT
2323rdrd
Year of Service
SITES
INTEGRATED CLINICAL RESEARCHSITES
BOOSTING THE INVESTIGATOR POOLTRIAL DESIGN
REMOTE PATIENT-CENTERED STUDIESTRIAL DESIGN
RISK-BASED MONITORING IN ACTION
NEXT ISSUE
Oncology Trials
Volume 24 Number 2/3 February/March 2015
ALSO IN THIS ISSUE:
■ New Drug Approval Momentum
■ mHealth in Clinical Trials
■ Simplifying Protocol Design
Clinical Trial Optimization
Volume 24
Num
ber 2/3
Clinical Trial Optim
ization aPPlied C
liniCa
l tr
ials
February/March 2
015
All Rates are gross
Online advertising options
2016 Online Rates (net)
ROS
Leaderboard 728×90 $ 2,600.00 up to 5 rotations
Banner 468×60 $ 2,600.00 up to 5 rotations
Skyscraper 160×600 $ 3,015.00 up to 5 rotations
Big Box 300×250 $ 2,600 up to 5 rotations
Interstitials 640×480 $ 5,395.00 exclusive
Page Peel170 x 127 (Corner Logo)and expand to 640 x 480 (Display)
$ 5,495.00 exclusive
Polite Footer/Floating Footer 970x90 expandable to 970×250 $ 5,250.00 exclusive
Sponsored Content Block $ 7,500.00$ 18,000.00
1 month3 months
Skyscraper Hangers in Gutter 128×620* or 160×600 $ 7,500.00 exclusive
Ad Retargeting
Tier Duration Impressions/3months Pricing
Silver 3 months 450,000 $6,000/3 months
Gold 3 months 900,000 $10,500/3 months
Platinum 3 months 1,500,000 $15,000/3 months
E-newsletters
Leaderboard 728×90 $ 2,295.00 1 positions available
Banner or Text 468×60 $ 1,675.00 4 positions available
Big Box 300×250 $ 2,295.00 2 positions available
Text Ad 65 words plus URL $ 1,675.00 2 positions available
Marketplace 100×100 company logo or image, up to 25 words of text, click URL $ 1,315.00
White Paper $ 1,575.00 per month
ACT TV $ 2,000.00 per month
e-Media Rate Card
* Preferred
WEBSITE AD DIMENSIONS
• Rectangle: 300 × 100 pixels; 40 KB max; GIF, JPEG, or *Flash accepted • Leaderboard: 728 × 90 pixels; 40 KB max; GIF, JPEG or *Flash accepted • Box : 300 × 250 pixels, 40 KB max; GIF, JPEG, or *Flash accepted• Sponsored link: Up to 10 words + url• Interstitial: 640 × 480 pixels; 40 KB max; GIF or JPEG, 3rd party tags accepted, but
must be standard html. NO Java Script tags. No fl ash ads accepted.• Polite/Floating Footer: 970x90 expandable to 970x250; 50 KB max; GIF or Animated GIF or JPEG, 1 Live Click URL + If submitting Flash, specifi c instructions will be supplied prior to ad creation
+ Materials are due 10 business days before desired run date
E-NEWSLETTER AD DIMENSIONS
• BannerAd Size: 468 × 60
• SkyscraperAd Size: 160 × 600
• ButtonAd Size: 120 × 60
• Text Ad65 words
• LeaderboardAd Size: 728 × 90
• Product Showcase 65 words1 product image (110 pixels wide)
Ad Size: For all banner ad sizes
• Max File Size: 40kb• Formats Accepted: Gif, Animated Gif or Jpg *No Flash/Rich Media accepted for eNews or Alerts* If
3rd party, only Click URL and 1 × 1 pixel tracker accepted with Gif, Animated Gif or Jpg.• 1 Live Click URL• Outlook 2007 and 2010 will serve an Animated GIF but they do not support animation- only
the fi rst frame will appear. Please note when creating animated GIF fi les, you’ll want to ensure the � rst frame carries the call to action and is not too ambiguous.
+ Materials are due 10 business days before desired issue date
CAST DATABASE PROGRAM
Materials must be provided by the sponsor
Materials needed for your CAST e-campaign:
1. HTML (“in line style” is required), please read the attached Email Design Basics/Specs very carefully. 2. Clients opt-out/unsubscribe link must be embedded in the HTML along with a physical address.3. Text version of the e-mail including the opt-out/unsubscribe link4. Subject Line5. From Line (friendly from line; e.g. the companies name or persons name. Not an e-mail address)6. Suppression fi le of clients opt-outs/unsubscribes7. Seed names and e-mail addresses of who needs to see the test and � nal blasts. We ask that only one of
the seed names be responsible for sending � nal approval of the test blast to [email protected].
There is a 48 hour turn-around time for our E-media team to deploy, the turn-around time starts AFTER all the above materials are received.
e-Media Project Submission GuidelinesWe offer HTML5 support for display ad creative. If submitting HTML5, specs will be supplied prior to ad creation.
Important information regarding your CAST e-campaigns:1. Deployment dates MUST be suggested or approved by Ronda Hughes.
2. Suppressions due to any threshold limits will be deployed as priority the day after the initial blast. Threshold limitations can be avoided when securing deployment dates ahead of time.
3. Clients using Advanstar’s design services as part of their CAST program will have up to 2 revisions free of charge, there is a $100 fee for changes thereafter and will run the risk of having to reschedule.
4. All HTML changes need to be made and approval sent back to Ronda Hughes 48 hours prior to scheduled deployment.
5. Test blasts are sent out at least one day prior to the fi nal blast to ensure proper HTML rendering. HTMLs need to be approved by the client prior to the test blast. Copy or design changes to the HTML after the test blast will result in a $100 fee AND will run the risk of having to reschedule.
6. Client needs to send approval of the test blast to [email protected] by the end of the day in which it was received in order to ensure the scheduled deployment date. Please have one seed name designated to give approval.
7. Email deployment reports will be sent to the sales representative 72 hours (3 days) after the blast.
PODCAST SERIES SPONSORSHIP
Custom specifi cations will be provided in the offi cial Podcast agreement
WEBCAST SPONSORSHIP
Custom specifi cations will be provided in the offi cial Webcast agreement
WHITE PAPER LEAD GENERATION
– White Paper in PDF format no more than 1.5 MB in size
– Your Company Name
– White Paper Title: 36 words
– Author(s): names only, not company affi liations
– White Paper abstract: a description of what the application note contains; 23 short sentences, maximum 50 word count total.
– Email Address where leads should be sent
– 13 keywords to be included in your lead email subject line as an identifi er for the White Paper
– Contact Name
– Contact Phone Number
– Logo (EPS, Jpeg, Gif format, max width: 150 pixels)
– URL Links: one URL with http:// in front of the www that links from your logo
– Company Text: 7–10 word maximum in plain text that describes your company
e-Media Project Submission Guidelines
e-Media Project Submission Guidelines
Submit Materials to:
Website and Newsletter Ad Materials: [email protected], eApplication notes, or eSolution Blasts: [email protected] list the Advertiser and Website in the subject line.
ACT TV
1. Company Logo • Acceptable formats: Jpg, Png, Gif • Dimensions: 160px × 100px OR smaller • Logo appears on a white background. White or transparent backgrounds preferred.
2. Short one sentence description of your company • 20 word description
3. Company Logo (for asset area) • Width: minimum 200px • Height: minimum 85px
4. Company Pro� le • < 75 word description of your company
ASSETS
You are allowed a total of 4 assets on your page, with a description, picture, and link to redirect to for each asset. Descriptions must be <75 words. An asset can be defi ned as:
• Whitepapers (.pdf format) • Case studies • Videos (formats: Youtube, or Link/url to be hosted on your site) • Webcasts • Product demonstrations • Description or link to product or service
____Asset 1 & Picture ____Description ____Asset 2 & Picture ____Description ____Asset 3 & Picture ____Description ____Asset 4 & Picture ____Description
Print & Online Sales Contacts
Mike Tessalone Vice President / Group Publisher
T: 732-346-3016 [email protected]
Laurie Marinone
Associate Publisher / East Coast Sales Manager T: 508-808-4723
Wayne Blow Sales Director
T: +44 (0) 7852-142-284 F: +44 (0) 1925-732 798 [email protected]
Bill Campbell
Regional Sales Manager Midwest, Southwest and West Coast
T: (847) 283-0129 F: (847) 282-1456
Joanne Capone Ad Coordinator T: 732-346-3031 F: 732-596-0012